T. Hidvegi et al., IN-VITRO COMPLEMENT ACTIVATION BY RAGWEED ALLERGEN EXTRACT IN THE SERA OF RAGWEED ALLERGIC AND NONALLERGIC PERSONS, Immunology letters, 48(1), 1995, pp. 65-71
Ragweed allergen (RWA)-induced complement activation in sera of 40 RW
allergic patients and of 40 non-allergic controls was investigated, Af
ter treatment of the sera with RWA, levels of C3a, C5a, C3bBbP, ClrCls
Clinh, SC5b-9 and granulocyte-aggregating activity were determined. Co
ncentration of RW-specific IgG was also measured. After RWA treatment
dose-dependent complement activation was detected in sera of RW allerg
ic and non-allergic persons. C3a generation was observed mostly in the
sera of RW allergic individuals, while levels of C3bBbP and of RW-spe
cific IgG were significantly higher in sera of allergies, and a strong
correlation was found between these two parameters. In a prospective
clinical study, a significant positive correlation was observed betwee
n the extent of RWA-induced alternative pathway (AP) activation and th
e severity of symptoms of allergic rhinoconjunctivitis that were devel
oped in a 4-week period subsequent to blood sampling. These observatio
ns suggest that complement activation has a role in the development of
the symptoms of RW allergy.